Sunday, 23 February 2020

24th February, 2020 Morning Brief

Market will open with a gap-down today after a spread of coronavirus outside China spooked global markets.

U.S. equity futures sank with Asian shares and gold surged after the number of coronavirus cases outside of China increased and concern grew that global economic growth could take a more sustained hit with shares in Seoul and Sydney trade lower. 

Tech companies were particularly hard hit, setting the Nasdaq 100 down almost 2%. The S&P 500 Index posted its first weekly decline since January.

🎯 News & Impact 🎯

🎯 Ambuja Cement (Q4CY19, YoY) :
Revenue rose 9.5 % to Rs 3,135.9 crore. 
Net profit fell 15.4 % to Rs 454.9 crore. 
Ebitda rose 35.6 % to Rs 547.5 crore.
Positive for the stock. 👍 

🎯 Bharti Infratel :
Company receives FDI Approval from DOT for the merger of Indus Towers on 21st Feb. 2020. 
Positive for the stock. 👍 

🎯 Axis Bank, Max Financial Services :
Max Life Insurance sign confidentiality and exclusivity arrangement to explore the possibility of Axis Bank to enter into a long-term strategic partnership with Max Life.

🎯 Tobacco Companies :
According to media reports, Health Ministry is mulling to increase the legal age for tobacco consumption from 18 to 21 years as part of its efforts to strengthen the provisions of Cigarettes and Other Tobacco Products Act.  

🎯 GMR Infrastructure 
French airports operator ADP, which operates Paris airports Roissy and Orly, has bought a 49 per cent stake in GMR Airports for 1.34 billion euros ($1.45 billion), ADP said on Thursday.  

🎯 PVR
Company opened 5 screens multiplex at Nilamber Triumph Mall, Vadodara.

🎯 Dr. Reddy :
Company’s gets EIR from the U.S. FDA for Duvvada formulations plant at Vizag, indicating closure of the audit. The facility has been classified at Voluntary Action Indicated.

🎯 AstraZeneca Pharma :
Company has launched QTERN tablets in India for the treatment of diabetes.

🎯 Aurobindo Pharma
U.S. FDA revokes voluntary action Initiated Status for Unit IV. It says Unit IV is still open and under review, U.S. FDA only had issued a ‘Voluntary Action Initiated’ status on Feb. 18.

🎯 Alkem Laboratories :
Company receives two observations under U.S. FDA inspection for its Baddi Facility. 

🎯 Biocon :
Company’s facility in Malaysia receives three observations under the U.S. FDA inspection.

🎯 GMR Infra : 
Aeroports de Paris agrees to buy a 49 percent stake in India’s GMR Airports for Rs 10,780 crore. The purchase to happen in two steps starting 24.99 percent in the coming days. The second step for 24.01 percent to require approvals from regulators includes RBI. 

🎯 Dilip Buildcon :
Company executed an EPC agreement with Airport Authority of India for the project “Construction of new greenfield airport at Hirasar, Rajkot, Gujarat”. 

🎯 M&M :
Mahindra renewables private limited, a step-down subsidiary of Mahindra and Mahindra to sell the entire stake in three of its wholly-owned subsidiary to CLP India Private Ltd.

🎯 Dixon Technologies :
Company promoter Sunil Vachani decreased his stake from 36.27 % to 34.67 % in the company on Feb. 20.

🎯 Electrosteel Castings :
Company promoter Murari Investment acquired 6.1 lakh shares from Feb. 18-19
Zensar Tech promoters acquired 2.7 lakh shares from Feb. 18-19. 
Positive for the stock. 👍 

🎯 Aarti Industries :
Company promoters sold 34,000 shares from Feb. 17-18. 
Negative for the stock. 

🎯 Sanghi Industries :
Company promoter Aditya Singhi and Alok Singhi acquired 13 lakh shares from Feb. 19-20. 
Positive for the stock. 👍 

🎯 Axis Bank :
Bank promoter General Insurance Corporation of India sold 2 lakh shares on Feb. 18. 
Negative for the stock. 

🎯 Sobha :
Company promoter Ravi Menon acquired 28,000 shares on Feb. 19. 
Positive for the stock. 👍 
✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒

Edited by Sharp. 

No comments:

Post a Comment